FiroCruz talks on import of 2 million doses of vaccines from India

FiroCruz talks on import of 2 million doses of vaccines from India

Fiocruz (Fundação Oswaldo Cruz) announced on Friday (February 12, 2021) that it was negotiating the import of 2 million doses of the vaccine manufactured by the AstraZanteca laboratory, in partnership with Instituto Serum from India. The objective is to guarantee the supply of antibodies, while the Brazilian unit produces new supplements in the national arena.

Earlier, Anvisa (National Health Monitoring Agency) approved the import of new doses of vaccine. It will be up to the Ministry of Health to decide whether it will hold only 2 million doses that Turquoise intends to import or if there will be new orders.

Earlier this year, the agency had already authorized the import of another 2 million doses of the vaccine produced in India.

continue reading

READ  Britain closed schools and took cancell exams until at least February
Cory Weinberg

About the author: Cory Weinberg

Cory Weinberg covers the intersection of tech and cities. That means digging into how startups and big tech companies are trying to reshape real estate, transportation, urban planning, and travel. Previously, he reported on Bay Area housing and commercial real estate for the San Francisco Business Times. He received a "best young journalist" award from the National Association of Real Estate Editors.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *